Genetic Testing Market and Forecast - Global Analysis 2010 - 2015
Renub Research
November 14, 2011 57 Pages - SKU: RNBR6671379
|
|
Countries covered: Global
Genetic Testing - Market Overview
The genetic testing market is witnessing a period of profound growth. Growing with a CAGR of 18 percent globally genetic testing market is expected to cross the figure of US$ 10 Billion by 2015. This significant growth is primarily attributed to the incidence of genetic diseases, burgeoning demand for molecular diagnostics, aging population, and subsequent increase in chronic diseases. Increasing knowledge about the potential benefits in genetic testing has been one of the prime reasons for the growth in genetic testing.
Pharmacogenomics is the most lucrative segment of genetic testing. Cancer genetic testing should post strong position in the genetic testing industry due to rising cases of cancer patients with the market share of around 23% in 2010 and it is expected that cancer genetic testing will lead the genetic testing market by 2015. The future growth in genetic testing is expected to come from prenatal and predisposition genetic testing.
Genetic testing is becoming an integral and growing part of healthcare provision and services.
Advancements in genetic testing, together with genetically engineered drugs, are expected to aid in tailoring personalized medicine for specific races, individuals, and families. The genetic testing sector will grow rapidly over the next 5 to 10 years and spread beyond the small number of specialist genetic centres.
Report Details
"Genetic Testing Market & Future Forecast - Global Analysis 2010 - 2015" report published by Renub Research provides an in-depth analysis of the past, present and future prospects. The report has been researched at source globally and features latest available data covering:
- Global Genetic Testing Market (2005 - 2015)
- Top 5 application wise genetic testing (Cancer Genetic Testing, Prenatal Genetic Testing, Predisposition Genetic Testing, Pharmacogenomics Genetic Testing) data of Past, Present and Future Market
- United States immigration genetic testing market
- Top Corporate past, present developments
- Top Laboratory Merger & Acquisition deals from 2007 - 2009
- Driving forces for the growth of global genetic testing market
- Challenges faced by genetic testing market in the coming years
- Key Players analysis in the genetic testing market
Research Highlights
- Globally, Genetic Testing market is expected to cross the figure of US$ 10 Billion by 2015
- Cancer Genetic testing dominates the Genetic Testing market with more than 35% market share by 2015
- Cancer Genetic Testing and Pharmacogenomics testing are likely growth leaders in the genetic testing market.
- Prenatal & Predisposition genetic testing will have a combined market share of 26% by 2015
Company Analysis
This section covers the key facts about the major companies that play an important role in Genetic Testing Market. The companies analyzed in this section are - Orchid Cellmark Inc, 23andMe, Pathway Genomics Corporation, Navigenics, Decode Genetic. All the companies have been analyzed from two points of view 1) Strength of the company in genetic testing market 2) Weakness of the company in genetic testing market.
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.
Information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.
|
- 1. Executive Summary
- 2. Global Genetic Testing Market
- 3. Genetic Testing Market Share & Future Forecast
- 4. Genetic Testing Market (Application Segment) 2005 - 2015
- 4.1 Cancer Genetic Testing Market
- 4.2 Prenatal Genetic Testing Market
- 4.3 Predisposition Genetic Testing Market
- 4.4 Pharmacogenomics Genetic Testing Market
- 5. Corporate Developments
- 5.1 LabCorp to Buy Genzyme's Genetic Testing Unit
- 5.2 DNA Testing Systems Inks Agreement with DNAPrint Genomics Inc.
- 5.3 Hologic to Acquire Third Wave Technologies
- 5.4 PerkinElmer Acquires Newborn Metabolic Screening Assets of Pediatrix
- 5.5 Affymetrix to Acquire Panomics
- 6. Laboratory Merger & Acquisition
- 7. Driving Forces for Genetic Testing
- 7.1 Present Development and Future of Genetic Testing Market
- 7.2 Increased Incidence of Cancer
- 7.3 Emerging Economies is Expected to Drive the Market in Future
- 7.4 Increasing Availability of Tests Allows More Patients to be Diagnosed
- 7.5 Availability of Direct-to-Consumer Tests to Increase Test Volumes
- 8. Challenges for Genetic Testing
- 8.1 Lack of a Coherent Oversight System to Ensure the Quality of Tests and Testing Laboratories
- 8.2 Dearth of Professional Guidelines for Conducting Genetic Tests
- 9. Companies Analysis
- 9.1 Orchid Cellmark Inc
- 9.1.1 Strengths
- 9.1.2 Weaknesses
- 9.2 23andMe
- 9.2.1 Strengths
- 9.2.2 Weaknesses
- 9.3 Pathway Genomics Corporation
- 9.3.1 Strengths
- 9.3.2 Weaknesses
- 9.4 Navigenics
- 9.4.1 Strengths
- 9.4.2 Weaknesses
- 9.5 deCODE Genetics
- 9.5.1 Strengths
- 9.5.2 Weaknesses
- List of Figures:
- Figure 2 1: Global - Genetic Testing Market (Million US$), 2005 - 2010
- Figure 2 2: Global - Forecast for Genetic Testing Market (Million US$), 2011 - 2015
- Figure 3 1: Global - Genetic Testing Market Share (Percent), 2008 - 2010
- Figure 3 2: Global - Forecast for Genetic Testing Market Share (Percent), 2011 - 2015
- Figure 4 1: Global - Cancer Genetic Testing Market (Million US$), 2000 - 2010
- Figure 4 2: Global - Forecast for Cancer Genetic Testing Market (Million US$), 2011 - 2015
- Figure 4 3: Global - Prenatal Genetic Testing Market (Million US$), 2000 - 2010
- Figure 4 4: Global - Forecast for Prenatal Genetic Testing Market (Million US$), 2011 - 2015
- Figure 4 5: Global - Predisposition Genetic Testing Market (Million US$), 2000 - 2010
- Figure 4 6: Global - Forecast for Predisposition Genetic Testing Market (Million US$), 2011 - 2015
- Figure 4 7: Global - Pharmacogenomics Genetic Testing Market (Million US$), 2005 - 2010
- Figure 4 8: Global - Forecast for Pharmacogenomics Genetic Testing Market (Million US$), 2011 - 2015
- Figure 5 1: United States - Immigration Testing Market (Million US$), 2007 - 2010
- Figure 5 2: United States - Forecast for Immigration Testing Market (Million US$), 2011 - 2015
- Figure 8 1: BRIC - In Vitro Diagnostic Market (Billion US$), 2009 - 2010
- Figure 8 2: BRIC - Forecast for In Vitro Diagnostic Market (Billion US$), 2011 - 2015
- Figure 8 3: Global - Growth of Laboratory Directory (Number), 2000 - 2010
- Figure 8 5: Global - Direct to Consumer Genetic Testing Market (Million US$), 2008 - 2010
- Figure 8 6: Global - Forecast for Direct to Consumer Genetic Testing Market (Million US$), 2011 - 2015
- Figure 10 1: Orchid Cellmark Inc Laboratories - Key Financials (Million US$) 2007 - 2009
- List of Tables:
- Table 6 1: LabCorp & Genzyme Genetic - Acquisitions (Million US$), 2010
- Table 6 2: Hologic & Third Wave Technologies - Acquisitions (Million US$), 2008
- Table 6 3: PerkinElmer Inc & Pediatrix Medical Group - Acquisitions 2008
- Table 6 4: Affymetrix & Panomics - Acquisitions (Million US$), 2008
- Table 7 1: Global - Laboratory Merger & Acquisition (Million US$), January 2007 - July 2009
- Table 8 1: Global - New Cancer Cases & Deaths & Forecast (Million), 2000 & 2020
- Table 8 2: Global - All Cancers (excluding non-melanoma Skin Cancer) Incidence and Mortality (Thousand), 2008
More Global Molecular Diagnostics Reports
In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers & Microbiology Culture) – Global Trends & Forecasts to 2016 by
MarketsandMarkets
The global in-vitro diagnostics (IVD) market was valued at $44 billion in 2011 and is expected to have a modest growth during the study period. ...
2012 World Molecular Diagnostics Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country by
Venture Planning Group
This report provides a worldwide overview of the molecular diagnostics market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as ...
2012 Global Molecular Diagnostics Market Outlook: Growth Opportunities and Strategies by
Venture Planning Group
The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next ten years will witness significant ...
The 2012 Global Molecular Diagnostics Market: Facilities, Test Volumes, and Sales Forecasts by Country by
Venture Planning Group
This report provides a worldwide overview of the molecular diagnostics market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as ...
Genetic Testing by
Global Industry Analysts
This report analyzes the worldwide markets for Genetic Testing in US$ Million. The US market is analyzed by the following Segments: Prenatal and Newborn Genetic ...
See all reports like this >>
Share this report
Other tasks Related Markets Molecular Diagnostics Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|